First Time Loading...

Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 37.94 USD 3.32% Market Closed
Updated: May 29, 2024

Biohaven Pharmaceutical Holding Company Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biohaven Pharmaceutical Holding Company Ltd
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Accounts Payable
$15.6m
CAGR 3-Years
77%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$31.3B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$622m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$1.6B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$351.4m
CAGR 3-Years
40%
CAGR 5-Years
34%
CAGR 10-Years
22%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$671.3m
CAGR 3-Years
7%
CAGR 5-Years
23%
CAGR 10-Years
35%

See Also

What is Biohaven Pharmaceutical Holding Company Ltd's Accounts Payable?
Accounts Payable
15.6m USD

Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Accounts Payable amounts to 15.6m USD.

What is Biohaven Pharmaceutical Holding Company Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
77%

Over the last year, the Accounts Payable growth was 46%. The average annual Accounts Payable growth rates for Biohaven Pharmaceutical Holding Company Ltd have been 77% over the past three years .